Related Experiment Video
Updated: May 17, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Pseudomonas aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran
Enayat Kalantar1, Shadi Taherzadeh, Tayeb Ghadimi
1Department of Microbiology, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. kalantar_enayat@yahoo.com
Abstract:
This study was conducted to determine the incidence of Pseudomonas aeruginosa infections among burn patients at Tohid Hospital, Iran. A total of 176 clinical specimens were obtained from 145 burn patients admitted to the burn unit of Tohid Hospital to detect the presence of P. aeruginosa. Antimicrobial susceptibility testing was conducted to detect extended spectrum beta-lactamase (ESBL) producing P. aeruginiosa using Clinical and Laboratory Standards Institute guidelines with the double disc synergy test (DDST). A polymerase chain reaction was used to detect PER-1 and OXA-10 among the isolates. The mean age, total body surface area and length of hospital stay among patients were 29 years, 37.7%, and 10 days, respectively. Kerosene was the commonest cause of burn (60%), followed by gas (30%). During the study, P. aeruginosa was detected in 100 isolates. The antibiotics they were most commonly resistant to were cefotaxime, ceftriaxone and ciprofloxacin. Of the 100 P. aeroginusa isolates, 28% were positive for ESBL production with the DDST, 48% and 52% were PER-1 and OXA-10 producers, respectively. The high frequency of PER-1 and OXA-10 producers at this hospital is of concern considering their potential spread among burn patients.
Insights
Pseudomonas aeruginosa infections are common in Iranian burn patients. High rates of antibiotic resistance, including extended-spectrum beta-lactamase (ESBL) producers, were observed, necessitating infection control measures.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Burn Care
Background:
- Burn injuries create a high risk for secondary infections.
- Pseudomonas aeruginosa is a significant opportunistic pathogen in burn wound infections.
- Antibiotic resistance in P. aeruginosa complicates treatment and increases morbidity.
Purpose of the Study:
- To determine the incidence of P. aeruginosa infections in burn patients at Tohid Hospital, Iran.
- To investigate antimicrobial resistance patterns, focusing on extended-spectrum beta-lactamase (ESBL) production.
- To identify the prevalence of specific resistance genes (PER-1 and OXA-10) in P. aeruginosa isolates.
Main Methods:
- Collection of 176 clinical specimens from 145 burn patients.
- Detection of P. aeruginosa using standard microbiological techniques.
- Antimicrobial susceptibility testing and double disc synergy test (DDST) for ESBL detection.
- Polymerase chain reaction (PCR) for PER-1 and OXA-10 gene identification.
Main Results:
- P. aeruginosa was detected in 100 isolates (incidence to be calculated based on total patients/specimens).
- Common resistance observed against cefotaxime, ceftriaxone, and ciprofloxacin.
- 28% of isolates were ESBL producers.
- 48% and 52% of isolates carried PER-1 and OXA-10 genes, respectively.
Conclusions:
- High prevalence of P. aeruginosa and significant rates of ESBL production, including PER-1 and OXA-10, in burn patients.
- The findings highlight a concerning trend of antibiotic resistance in this patient population.
- Urgent implementation of infection control strategies is recommended to prevent the spread of resistant strains.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...

